Articles tagged with Antibiotics
A new label indicating responsible antibiotic use (RAU) in dairy milk could entice conventional farmers to minimize antibiotics, with half of US adults willing to buy RAU-labeled milk. The price point would need to be competitive with conventional milk, but consumers are more willing to pay for the label.
A new treatment option for multi-resistant bacteria has been identified by a UNIGE team, which uses the drug edoxudine to weaken the defence mechanisms of Klebsiella pneumoniae, making it easier to eliminate. This approach could be a game-changer in the fight against antibiotic resistance.
A major clinical trial found that a short course of antibiotics can significantly reduce the risk of stomach bleeding caused by regular aspirin use, potentially improving its safety. The study involved 30,166 patients taking aspirin and showed rapid protection from hospital admissions for ulcer bleeding.
Researchers at UIC have developed a new method to study ribosome function by attaching peptides to tRNAs, providing high-resolution structures of the ribosome and its interactions with nascent chains. This breakthrough sheds light on protein synthesis and antibiotic resistance.
Researchers at Osaka University have discovered the spatial characteristics of an efflux pump that helps bacteria resist antibiotics. By analyzing a specific inhibitor's binding site, they found bulky mutations can prevent the inhibitor from working, offering hope for developing new countermeasures to combat antibiotic resistance.
Researchers have developed a way to load potent antibiotics like Polymyxin B into red blood cells, allowing them to selectively target and kill drug-resistant bacteria. This technology could help address the ongoing antibiotic resistance crisis and deliver drugs more quickly and directly to specific sites in the body.
A new drug combination of cefepime and enmetazobactam has been found to be more effective in treating complicated urinary tract infections and acute pyelonephritis than a standard treatment. The study showed that the new combination was successful in treating 79% of patients, compared to 58.9% for the conventional treatment.
Researchers found a significant association between NTM infection and increased mortality in patients with end-stage renal disease. Early diagnosis and treatment may improve survival. NTM can cause nonspecific symptoms like fever and weight loss, and patients with compromised immune systems are at higher risk.
A recent study by University of Gothenburg researchers found that nearly twice as many Swedes are willing to obtain antibiotics without prescriptions than previously thought. Trust in healthcare plays a significant role in this behavior, with low trust linked to increased prescription without a doctor's order.
A collaborative team at IGB discovered 30 new compounds, including three with antibacterial properties, using the Illinois Biological Foundry for Advanced Biomanufacturing. The platform allowed for rapid screening of hundreds of genes and pathways, enabling the researchers to identify potential anti-microbial compounds.
Researchers at UCalgary have shown that the antibiotic D-Cycloserine (DCS) increases the effectiveness of transcranial magnetic stimulation (TMS) for people with major depressive disorder. The combination treatment showed significant benefits, including improved depressive symptoms and anxiety levels.
Research by the University of Exeter found high levels of antibiotic ciprofloxacin in UK wastewater, posing a significant risk to human health. The study suggests that antibiotic pollution from human waste can increase resistance to antibiotics, even in countries with well-established sanitation infrastructures.
A new study published in the European Respiratory Journal found that early treatment with anti-anaerobic antibiotics can deplete gut anaerobes and lead to worse clinical outcomes. The research suggests that these 'good bugs' protect against pneumonia, organ failure, and mortality.
Researchers at the University of Basel have discovered a new antibiotic, Dynobactin, effective against resistant Gram-negative bacteria. The compound blocks bacterial membrane protein BamA, preventing its job and killing the bacteria. This finding offers a boost to antibiotics research and could lead to more effective drugs.
Researchers have discovered a novel antimicrobial compound, evybactin, that selectively targets Mycobacterium tuberculosis, a bacteria that causes tuberculosis. This breakthrough could lead to the development of new treatments for tuberculosis without contributing to antibiotic resistance.
Researchers found a 'zero-price effect' in Japan's child healthcare system, where zero cost increases demand for health services. However, this can lead to poor allocation of resources and overuse of antibiotics.
A secondary analysis of a randomized clinical trial found that positive patient beliefs about antibiotic effectiveness for appendicitis are linked to lower risk of surgery and faster symptom resolution. This association remains unclear, with further research needed to understand its underlying mechanisms.
A randomized clinical trial and meta-analysis found that antibiotic eye drops significantly shortened symptoms of conjunctivitis in children. The study's results suggest a promising treatment option for this common childhood condition.
Researchers found that Fecal Microbiota Transplant (FMT) using capsules has a cure rate of 86% at one month and 81% at two months for recurrent CDI, comparable to colonoscopic FMT. Patient selection is key to optimizing FMT success.
Researchers at Brigham and Women's Hospital and MIT have developed RoboCap, a robotic capsule that delivers drugs to the gut by clearing mucus and churning to enhance absorption. In preclinical models, RoboCap increased drug permeability by over 10-fold for insulin and vancomycin.
Researchers found that discounted prices were 1.5 times higher for human medications than for pet medications, affecting over 60% of medications.
Researchers at Indiana University School of Medicine have identified the autophagy pathway in hair cells linked to permanent hearing loss caused by aminoglycosides. The study developed laboratory models with reduced RIPOR2 expression, which did not exhibit hair cell death or hearing loss when treated with antibiotics.
A new guideline published in Clinical & Experimental Allergy aims to improve the testing process for penicillin allergies among patients. The guidelines provide recommendations on patient selection, risk stratification, and drug provocation testing, aiming to reduce errors and ensure accurate diagnosis.
Researchers found that poor infrastructures, low awareness, and unstable funding hinder efforts to implement global guidelines for antimicrobial resistance. The study highlights the need for tailored interventions responsive to local needs.
A new study led by NYU researchers has developed a topical gel that targets the succinate receptor to suppress inflammation, reduce bacterial imbalance, and prevent bone loss. The treatment has shown promise in reducing gum disease symptoms, including inflammation and tooth loss.
Researchers have engineered an enzyme that can degrade the capsule of antibiotic-resistant B. anthracis bacteria, making it susceptible to the immune system. The new treatment, which combines the enzyme with a mouse antibody, shows promise in treating anthrax infections without antibiotics.
Using artificial intelligence, researchers from Tufts University have devised rules for faster and more effective identification of potential new drug cocktails against tuberculosis. The study developed a set of design principles to assemble drug combinations, reducing the amount of testing needed before moving to further study.
The Society for Healthcare Epidemiology of America highlights the need to strengthen antibiotic stewardship programs to address overuse of antibiotics in early stages of viral epidemics. The guidance provides strategies for hospitals and healthcare personnel to improve antibiotic prescribing and diagnostic testing.
Researchers at Imperial College London discovered a 'silent' mutation in bacteria that helps them evade antibiotics. The mutation alters the structure of an mRNA intermediate, preventing ribosomes from producing protein, and has arisen independently several times globally.
Scientists at Aston University developed a new treatment combining manuka honey with the widely used antibiotic amikacin to treat drug-resistant lung infections. The study found that this combination improved bacterial clearance and reduced side effects, benefiting patients with cystic fibrosis.
A novel method developed by Brazilian researchers can analyze bacterial samples without isolating live bacteria, making it easier to detect antibiotic resistance in Streptococcus pneumoniae. The technique was tested on 873 samples and found that 51% were sensitive to antibiotics, while 17% were resistant.
A new study reveals that exploiting mitohormesis, a biological phenomenon where mild cellular stress boosts health and viability, can induce tolerance to influenza infection. Researchers identified a novel molecule, 9-tert-butyldoxycycline, which triggers beneficial mitochondrial responses that reduce tissue damage and inflammation.
Researchers developed a light-based therapy, photodynamic therapy (aPDT), to combat antibiotic-resistant bacteria. The treatment showed promise in weakening bacteria, allowing lower doses of current antibiotics to effectively eliminate them.
A University of the Basque Country team has successfully produced starch-based pharmaceutical tablets using 3D printing technology. The tablets display varying release properties depending on the type of starch used, offering promising solutions for personalized medicine and tailored drug delivery.
A new study from the University of Sheffield suggests that giving antibiotics to those at high risk of developing a life-threatening heart infection significantly reduces their risk. Current UK guidelines against routine use of antibiotics for these patients may be putting them at unnecessary extra risk.
Researchers have discovered a new molecule, fabimycin, that effectively treats over 300 drug-resistant bacteria in lab experiments and mice with pneumonia and urinary tract infections. The compound reduces the amount of drug-resistant bacteria to pre-infection levels or below, outperforming existing antibiotics at similar doses.
A massive analysis of over 10,000 Mycobacterium tuberculosis isolates revealed new genes associated with resistance to 13 antibiotics. The study provides a comprehensive framework for understanding the genetic mechanisms of resistance and identifying diagnostic gaps.
A new biosynthesis method has been developed to produce antibiotics from natural substances with added fluorine, which can strengthen bonding and improve accessibility. This technology has huge potential for optimizing polyketides, a gigantic substance class used in various medicines.
Researchers at TUM have developed a cell-free production method for bacteriophages, which can be used to target and combat specific types of antibiotic-resistant bacteria. The new technology has the potential to produce personalized therapeutic phages for clinical trials, addressing multi-resistant germ infections.
Researchers have discovered a new mechanism that some bacteria use to evade rifamycin antibiotics, showing antimicrobial resistance is more complex and evolved than previously recognized. The discovery has implications for finding new antibiotics and combating the growing global health threat of antimicrobial resistance.
A new study published in Mucosal Immunology demonstrates that early exposure to antibiotics can cause asthma and allergies in children. Researchers found that antibiotics alter the gut microbiome, leading to unwanted immune responses and increased allergy risk in later life.
A systematic review and meta-analysis found no significant differences in treatment success between nonoperative and operative management for acute uncomplicated appendicitis. However, the nonoperative group experienced significantly longer hospital stays and higher recurrence rates.
Researchers used a new tool to capture hundreds of undiscovered mechanisms of gene regulation in MRSA, revealing a previously unknown layer of gene regulation. The study identified a regulatory RNA that promotes an enzyme involved in cell wall thickening, potentially identifying new targets for antibiotic treatment.
Two studies found that dogs fed on a diet of raw meat were more likely to excrete antibiotic-resistant E. coli in their faeces. The research suggests that not feeding raw meat to dogs may help reduce the circulation of critically important antibiotic-resistant bacteria.
NC State researchers discovered a new way to make the difficult-to-characterize gut bacterium Bifidobacterium more responsive to antibiotics. They also found tiny changes in different strains that reflect large differences in their characteristics, highlighting the need for individualized CRISPR-based genome engineering approaches.
A new report highlights the importance of acknowledging antimicrobial resistance (AMR) in regulatory frameworks for accelerated drug approval. The analysis provides recommendations to improve access to new antibiotics in Brazil, India, and South Africa, where antibiotic development is hampered by regulatory hurdles.
Researchers at Ben-Gurion University have found a phytochemical derived from broccoli that breaks down biofilms protecting antibiotic-resistant pathogens, enabling eradication rates of up to 94% when combined with antibiotics. The compound also accelerates wound healing and is being further developed for commercialization.
Scientists have found that prior exposure to Staphylococcus aureus prevents effective vaccination due to immune response memory. To overcome this, the research suggests targeting only the protective component of the protein IsdB, generating a more effective vaccine against MRSA.
The PARROT trial aims to investigate whether long-term antibiotic treatment can reduce the impact of chest infections on children with neurological impairments. The UK-Australia joint trial will recruit 500 participants aged 3-17 years and assess rates of hospital visits, infections, and quality of life.
Outpatient antibiotic management of selected patients with appendicitis is safe, allowing many to avoid surgery and hospitalization. This treatment approach is associated with fewer serious adverse effects compared to hospitalization.
A new study found that the O139 cholera variant lost antimicrobial resistance and changed toxin production, leading to its unexpected decline. The findings suggest continuous monitoring of genetic changes is key to preventing future outbreaks.
A machine learning model has been developed to predict TB resistance to fluoroquinolones, which could speed up treatment. The model uses demographic and clinical factors to estimate the probability of resistance, allowing clinicians to optimize treatment regimens before test results are available.
Researchers have deciphered the exact bacterial adhesion mechanism using Bartonella henselae, revealing a key role for trimeric autotransporter adhesins and their interaction with fibronectin. Experimental blocking of these processes almost entirely prevents bacterial adhesion.
A three-year study found that telehealth consultations with a pediatric infectious disease specialist reduced antibiotic usage in 8 Texas nurseries serving rural and medically underserved areas by 32%. The consultations helped healthcare providers make more informed decisions about when to use antibiotics, ensuring the proper balance b...
A new therapeutic target for melioidosis has been identified by researchers at the Leibniz Institute for Natural Product Research and Infection Biology. The enzyme BurG synthesizes a toxic molecule central to infection, and inhibiting it could make bacteria less virulent.
A highly antibiotic-resistant strain of MRSA has emerged in livestock over the past 50 years, primarily due to widespread antibiotic use in pig farming. The CC398 strain has maintained its resistance and is capable of rapidly adapting to human hosts, posing a significant threat to public health.
Researchers from the University of Würzburg have developed precision antibacterials using mRNA technology, targeting specific genes in uropathogenic Escherichia coli. The study shows that these active agents can effectively block only one specific gene, and reducing their size to nine base pairs can minimize non-specific binding.
Bacteria's extreme lifestyle change during UTI infection cycles may hold clues to combating antimicrobial resistance and damage. Researchers used advanced microscopy to study the reversal of filamentation, shedding light on a previously unknown mechanism.
New research shows a decrease in antibiotic use, treatment within 48 hours, and broad-spectrum antibiotics among patients with signs of systemic inflammatory response syndrome (SIRS). The study found improvements in mortality rates and development of multi-drug resistant bacteria without increasing antibiotic overuse.
A new study published in iScience found that the co-development of the gut microbiome, immune system, and respiratory system is correlated with a baby's respiratory health. Disruption of any of these systems resulted in greater respiratory morbidity for infants, highlighting the importance of timing in intervening with therapies.